Lhasa Limited shared knowledge shared progress
Loading...

Publications

Jump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
TitlePublishedTypeProducts
Management of pharmaceutical ICH M7 (Q)SAR predictions – The impact of model updatesNovember 2020Derek NexusSarah NexusVitic Nexus
The importance of expert review to clarify ambiguous situations for (Q)SAR predictions under ICH M7September 2020Derek NexusSarah Nexus
ICH M7 Expert Review Workshop: Resolving common prediction scenarios using automated arguments in Nexus 2.3 (Webinar Presentation Slides)September 2020pdf fileDerek NexusSarah Nexus
Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity dataSeptember 2020Derek NexusSarah NexusVitic Nexus
Do all nitrosamines pose a significant level of genotoxic risk? (Webinar Presentation Slides)July 2020pdf fileDerek NexusSarah Nexus
ICH M7 Workshop Japanese ICGM 2019July 2020pdf fileSetariaSarah NexusMirabilisVitic NexusDerek Nexus
Lhasa Knowledge Suite Nexus 2.3 Release NotesJune 2020pdf fileDerek NexusSarah Nexus
Sarah Nexus Mutagenicity QMRF.pdfJune 2020pdf fileSarah Nexus
The application of in silico models to support decision making in toxicologyMay 2020pdf fileDerek NexusSetariaVitic NexusZenethMirabilisSarah NexusEffirisKaptis
In silico workflow under ICH M7March 2020pdf fileDerek NexusSetariaVitic NexusSarah Nexus
ICH M7 Workshop - 2020 ICH M7 India RoadshowsMarch 2020pdf fileDerek NexusSarah NexusZenethVitic NexusSetariaMirabilis
Predictions, Data and ICH M7 - 2020 ICH M7 India RoadshowsMarch 2020pdf fileDerek NexusSarah NexusVitic NexusSetaria
Lhasa and the ICH M7 Guideline - 2020 ICH M7 India RoadshowMarch 2020pdf fileDerek NexusSarah NexusVitic NexusSetariaMirabilis
GSK MI risk assessment process Camicinal at al - 2020 ICH M7 India RoadshowMarch 2020pdf fileDerek NexusSarah NexusVitic Nexus
Hazard Assessment of Potentially Mutagenic Impurities - 2020 ICH M7 India RoadshowsMarch 2020pdf fileDerek NexusSarah Nexus
ICH M7 - Regulatory Updates and Industry Practices - 2020 ICH M7 India RoadshowsMarch 2020pdf fileDerek NexusSarah Nexus
Lhasa Expert Review Developments - 2020 ICH M7 India RoadshowsMarch 2020pdf fileDerek NexusSarah NexusVitic Nexus
Product Update 2019November 2019pdf fileDerek NexusSarah NexusZenethVitic NexusSetariaMirabilisMeteor NexusKaptisEffiris
Predictive Toxicology: Using In Silico SystemsOctober 2019pdf fileDerek NexusSarah Nexus
ICH M7 - Risk assessment for mutagenic impurities and control strategiesSeptember 2019Derek NexusMirabilisSarah Nexus
Toxicity Evaluation of Degradation ProductsJuly 2019pdf fileDerek NexusSarah NexusZeneth
(Q)SAR Evaluation of Drug Impurities from the US FDA Scientific PerspectiveJuly 2019pdf fileDerek NexusSarah Nexus
Managing Mutagenic Impurity Risks in Pharmaceutical ProductsJuly 2019pdf fileDerek NexusSarah Nexus
In silico prediction of MutagenicityJune 2019pdf fileSarah NexusDerek Nexus
Use of In Silico Tools for Toxicity Prediction Within ICH M7June 2019pdf fileDerek NexusSarah NexusVitic Nexus

© 2020 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.